ESR Testing in Polymyalgia Rheumatica Evaluation
Yes, you should obtain an ESR as part of the baseline laboratory workup for suspected polymyalgia rheumatica, but recognize that a normal ESR does not exclude the diagnosis. 1
Why ESR is Part of the Standard Workup
The 2015 EULAR/ACR guidelines explicitly recommend documenting a minimal clinical and laboratory dataset before prescribing therapy for PMR, which includes ESR and/or C-reactive protein 1. This serves multiple purposes:
- Establishes baseline inflammatory markers for monitoring treatment response
- Helps exclude mimicking conditions (infections, malignancies, other inflammatory diseases)
- Guides initial glucocorticoid dosing: High ESR (>40 mm/1st hour) is associated with higher relapse risk and may favor starting at the higher end of the 12.5-25 mg prednisone dose range 1
- Provides prognostic information: Elevated ESR has been linked to prolonged therapy requirements in some studies 1
Critical Caveat: Normal ESR Does Not Rule Out PMR
Between 7-22% of patients with genuine PMR have normal or only slightly elevated ESR at diagnosis 2, 3. This subset of patients:
- Tends to be younger and more often male
- Has less severe constitutional symptoms (less fever, weight loss)
- Shows less anemia and fewer protein electrophoresis abnormalities
- Still responds dramatically to low-dose corticosteroids 2, 3
The 2015 guidelines specifically note that atypical presentations including low inflammatory markers warrant specialist referral 1, acknowledging that PMR can present without elevated ESR.
Practical Approach
When evaluating suspected PMR:
- Always obtain ESR (and/or CRP) as part of the baseline workup 1
- If ESR is elevated (>40 mm/hour): This supports the diagnosis and helps guide initial dosing
- If ESR is normal or low:
- Do not automatically exclude PMR 2, 4
- Check C-reactive protein - many patients with normal ESR have elevated CRP 2
- Consider shoulder ultrasound showing bilateral subdeltoid bursitis, which occurs in ~90% of PMR cases regardless of ESR 5
- Apply stricter clinical criteria to avoid over-diagnosis 2
- Consider specialist referral 1
Monitoring Role
Beyond diagnosis, ESR becomes valuable for monitoring disease activity during treatment and tapering 6, 7. The 2024 treat-to-target recommendations note that relapses may occur despite normal acute phase reactants, particularly with IL-6 receptor blockers 8, so clinical assessment remains paramount.
Bottom line: ESR is a required component of the PMR workup per guidelines, but clinical judgment supersedes laboratory values - treat the patient, not the number.